Skip to main content
. Author manuscript; available in PMC: 2020 Apr 12.
Published in final edited form as: Expert Rev Hematol. 2019 Apr 12;12(4):215–224. doi: 10.1080/17474086.2019.1592673

Figure 1: Pros and cons of next-generation sequencing in MDS.

Figure 1:

Next-generation sequencing (NGS) has several advantages and promising features in the diagnosis, treatment, and prognosis of MDS patients. However, several challenges remain which currently limit its use in routine clinical practice.